Literature DB >> 16513852

Stimulant medications: how to minimize their reinforcing effects?

Nora D Volkow.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16513852     DOI: 10.1176/appi.ajp.163.3.359

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  19 in total

1.  Sharing and selling of prescription medications in a college student sample.

Authors:  Laura M Garnier; Amelia M Arria; Kimberly M Caldeira; Kathryn B Vincent; Kevin E O'Grady; Eric D Wish
Journal:  J Clin Psychiatry       Date:  2010-03       Impact factor: 4.384

Review 2.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

3.  The novel N-substituted benztropine analog GA2-50 possesses pharmacokinetic and pharmacodynamic profiles favorable for a candidate substitute medication for cocaine abuse.

Authors:  Ahmed A Othman; Amy H Newman; Natalie D Eddington
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

4.  Associations Between Body Weight Status and Substance Use Among African American Women in Baltimore, Maryland: The CHAT Study.

Authors:  Ji Li; Cui Yang; Melissa Davey-Rothwell; Carl Latkin
Journal:  Subst Use Misuse       Date:  2016-04-06       Impact factor: 2.164

5.  Drugs for kids: good or bad?

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2012-09       Impact factor: 6.186

6.  rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts.

Authors:  Kenneth Blum; Yijun Liu; Wei Wang; Yarong Wang; Yi Zhang; Marlene Oscar-Berman; Andrew Smolen; Marcelo Febo; David Han; Thomas Simpatico; Frans J Cronjé; Zsolt Demetrovics; Mark S Gold
Journal:  Postgrad Med       Date:  2014-12-16       Impact factor: 3.840

7.  Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.

Authors:  P K Thanos; C Bermeo; M Rubinstein; K L Suchland; G J Wang; D K Grandy; N D Volkow
Journal:  J Psychopharmacol       Date:  2009-03-12       Impact factor: 4.153

8.  Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice.

Authors:  Aygul Balcioglu; Jia-Qian Ren; Deirdre McCarthy; Thomas J Spencer; Joseph Biederman; Pradeep G Bhide
Journal:  Neuropharmacology       Date:  2009-07-22       Impact factor: 5.250

9.  Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use.

Authors:  Amelia M Arria; Kimberly M Caldeira; Kevin E O'Grady; Kathryn B Vincent; Erin P Johnson; Eric D Wish
Journal:  Pharmacotherapy       Date:  2008-02       Impact factor: 4.705

10.  The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone.

Authors:  Thomas J Spencer; Pradeep Bhide; Jinmin Zhu; Stephen V Faraone; Maura Fitzgerald; Amy M Yule; Mai Uchida; Andrea E Spencer; Anna M Hall; Ariana J Koster; Leah Feinberg; Sarah Kassabian; Barbara Storch; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.